$CTGO
Contango ORE, Inc.

2017 Q2 Form 10-Q Financial Statement

#000143774917008446 Filed on May 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $770.0K $520.0K $270.0K
YoY Change 185.19% 188.89% -3.57%
% of Gross Profit
Research & Development $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $770.0K $520.0K $270.0K
YoY Change 185.19% 188.89% -6.9%
Operating Profit
YoY Change
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$770.0K -$520.0K -$270.0K
YoY Change 185.19% 188.89% -82.69%
Income Tax
% Of Pretax Income
Net Earnings -$770.0K -$516.9K -$270.0K
YoY Change 185.19% 185.19% -82.69%
Net Earnings / Revenue
Basic Earnings Per Share -$0.11
Diluted Earnings Per Share -$157.1K -$0.11 -$68.18K
COMMON SHARES
Basic Shares Outstanding 4.904M 4.904M 3.959M shares
Diluted Shares Outstanding 4.904M

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.190M $5.650M $1.250M
YoY Change 315.2% 318.52% -35.9%
Cash & Equivalents $5.192M $5.648M $1.254M
Short-Term Investments
Other Short-Term Assets $180.0K $80.00K $60.00K
YoY Change 200.0% -11.11% -14.29%
Inventory
Prepaid Expenses $175.8K $78.12K $175.8K
Receivables
Other Receivables
Total Short-Term Assets $5.368M $5.726M $1.313M
YoY Change 308.91% 299.64% -34.84%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.368M $5.726M $1.313M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $5.368M $5.726M $1.313M
YoY Change 308.91% 299.64% -34.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.86K $20.64K $20.85K
YoY Change 143.88% 5.08% -16.17%
Accrued Expenses $86.56K $82.22K $92.88K
YoY Change -6.81% 480.19% 18.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $137.4K $102.9K $113.7K
YoY Change 20.82% 204.18% 10.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $137.4K $102.9K $113.7K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $140.0K $100.0K $110.0K
YoY Change 27.27% 233.33% 10.0%
SHAREHOLDERS EQUITY
Retained Earnings -$35.11M -$34.34M -$32.28M
YoY Change 8.79% 7.3% 3.93%
Common Stock $40.55M $40.13M $33.47M
YoY Change 21.14% 20.15% 1.54%
Preferred Stock
YoY Change
Treasury Stock (at cost) $207.4K $171.2K
YoY Change
Treasury Stock Shares $9.068K $7.185K $0.00
Shareholders Equity $5.230M $5.623M $1.199M
YoY Change
Total Liabilities & Shareholders Equity $5.368M $5.726M $1.313M
YoY Change 308.91% 299.64% -34.84%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q2
OPERATING ACTIVITIES
Net Income -$770.0K -$516.9K -$270.0K
YoY Change 185.19% 185.19% -82.69%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$420.0K -$140.0K -$90.00K
YoY Change 366.67% 40.0% -18.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.00K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -420.0K -140.0K -90.00K
Cash From Investing Activities
Cash From Financing Activities -40.00K 0.000
Net Change In Cash -460.0K -140.0K -90.00K
YoY Change 411.11% 40.0% -18.18%
FREE CASH FLOW
Cash From Operating Activities -$420.0K -$140.0K -$90.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4903766
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Trading Symbol
TradingSymbol
ctgo
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001502377
dei Entity Registrant Name
EntityRegistrantName
Contango ORE, Inc.
CY2017Q1 ctgo Costs Of Unproved Properties Excluded From Amortization Mining Properties Period Cost
CostsOfUnprovedPropertiesExcludedFromAmortizationMiningPropertiesPeriodCost
0
CY2016Q1 ctgo Costs Of Unproved Properties Excluded From Amortization Mining Properties Period Cost
CostsOfUnprovedPropertiesExcludedFromAmortizationMiningPropertiesPeriodCost
ctgo Costs Of Unproved Properties Excluded From Amortization Mining Properties Period Cost
CostsOfUnprovedPropertiesExcludedFromAmortizationMiningPropertiesPeriodCost
ctgo Costs Of Unproved Properties Excluded From Amortization Mining Properties Period Cost
CostsOfUnprovedPropertiesExcludedFromAmortizationMiningPropertiesPeriodCost
14425
CY2017Q1 ctgo Exploration Costs And Claim Rentals Mining Properties Period Cost
ExplorationCostsAndClaimRentalsMiningPropertiesPeriodCost
0
CY2016Q1 ctgo Exploration Costs And Claim Rentals Mining Properties Period Cost
ExplorationCostsAndClaimRentalsMiningPropertiesPeriodCost
ctgo Exploration Costs And Claim Rentals Mining Properties Period Cost
ExplorationCostsAndClaimRentalsMiningPropertiesPeriodCost
ctgo Exploration Costs And Claim Rentals Mining Properties Period Cost
ExplorationCostsAndClaimRentalsMiningPropertiesPeriodCost
14425
CY2017Q1 ctgo Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
CY2017Q1 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
887999
CY2016Q2 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
1635999
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
20644
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20854
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82219
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92884
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
40085530
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33434899
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
171158
CY2017Q1 us-gaap Assets
Assets
5726056
CY2016Q2 us-gaap Assets
Assets
1312654
CY2017Q1 us-gaap Assets Current
AssetsCurrent
5726056
CY2016Q2 us-gaap Assets Current
AssetsCurrent
1312654
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4910951
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3958540
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4903766
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3958540
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
49110
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
39585
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
516929
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
181257
us-gaap Costs And Expenses
CostsAndExpenses
2064721
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Basis of Presentation</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 24pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;), including instructions to Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q and Article <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> of Regulation S-X. Accordingly, they do not include all the information and footnotes required by GAAP for complete annual consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair statement of the consolidated financial statements have been included. All such adjustments are of a normal recurring nature. The consolidated financial statements should be read in conjunction with the audited financial statements and notes included in the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The results of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>&nbsp;are not necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be expected for the fiscal year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div></div>
CY2017Q1 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
CY2016Q1 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
14425
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5647941
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254489
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1947046
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1346337
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4393452
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-600709
CY2017Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
887999
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Costs And Expenses
CostsAndExpenses
949907
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2017Q1 us-gaap Equity Method Investments
EquityMethodInvestments
CY2016Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
516929
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
181257
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2064721
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
935482
CY2017Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2016Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10875
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-69163
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
19950
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
19091
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5726056
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1312654
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
102863
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
113738
CY2017Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2016Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
us-gaap Share Based Compensation
ShareBasedCompensation
1372656
us-gaap Share Based Compensation
ShareBasedCompensation
437452
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
us-gaap Profit Loss
ProfitLoss
-2064721
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34340289
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32275568
CY2010Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1600000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5116342
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-722890
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-600709
us-gaap Net Income Loss
NetIncomeLoss
-2064721
us-gaap Net Income Loss
NetIncomeLoss
-949907
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-516929
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-181257
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
171158
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
78115
CY2016Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58165
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5287500
us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
5287500
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1372656
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
5623193
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1198916
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7185
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
171158
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4509950
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3918430
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Management Estimates.</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div>
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4903766
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3957640
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4509950
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3918430
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4903766
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3957640
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4509950
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3918430
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4903766
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3957640

Files In Submission

Name View Source Status
0001437749-17-008446-index-headers.html Edgar Link pending
0001437749-17-008446-index.html Edgar Link pending
0001437749-17-008446.txt Edgar Link pending
0001437749-17-008446-xbrl.zip Edgar Link pending
a2015ph1ddhwithzones12.jpg Edgar Link pending
a2015ph2ddhwithzones1.jpg Edgar Link pending
a2016phase1explorationprogra.jpg Edgar Link pending
conta20170331_10q.htm Edgar Link pending
ctgo-20170331.xml Edgar Link completed
ctgo-20170331.xsd Edgar Link pending
ctgo-20170331_cal.xml Edgar Link unprocessable
ctgo-20170331_def.xml Edgar Link unprocessable
ctgo-20170331_lab.xml Edgar Link unprocessable
ctgo-20170331_pre.xml Edgar Link unprocessable
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
phaseiiimap.jpg Edgar Link pending
phaseimap.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tetlinmapphaseii2016program.jpg Edgar Link pending